Last reviewed · How we verify
Safety, Tolerability, and Pharmacokinetics of a Single Dose of StaccatoTM Alprazolam for Inhalation in Normal, Healthy Volunteers
We are developing Staccato Alprazolam for the acute treatment of panic attacks associated with panic disorder.
Details
| Lead sponsor | Alexza Pharmaceuticals, Inc. |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 50 |
| Start date | 2005-06 |
| Completion | 2005-08 |
Conditions
- Healthy
Interventions
- Alprazolam thermal aerosol
Primary outcomes
- Pharmacokinetic profile and dose proportionality